ORTHOFIX MEDICAL INC. Stock Unit Grant Agreement COVER SHEETStock Unit Grant Agreement • July 15th, 2024 • Orthofix Medical Inc. • Surgical & medical instruments & apparatus • Delaware
Orthofix Medical Inc., a Delaware corporation (the “Company”), hereby grants to the Grantee named below, on the Grant Date set forth below, the specified number of Stock Units relating to shares of the Company’s common stock, par value $0.10 per share (the “Stock”), under the Plan, subject to the vesting schedule and terms and conditions set forth below (the “Award”). Additional terms and conditions of the Stock Units are set forth on this cover sheet, in the attached Stock Unit Grant Agreement (together, the “Agreement”), in the Company’s 2024 CHRO Inducement Plan (as amended from time to time, the “Plan”), and in the Change in Control and Severance Agreement between the Company and the Grantee (or if the Grantee is not party such an agreement, the Company’s standard form of such agreement) (the “CIC and Severance Agreement”). Capitalized terms used and not otherwise defined herein shall have the meanings attributed thereto in the Plan.
ORTHOFIX MEDICAL INC. Nonqualified Stock Option Grant Agreement COVER SHEETNonqualified Stock Option Grant Agreement • July 15th, 2024 • Orthofix Medical Inc. • Surgical & medical instruments & apparatus • Delaware
Orthofix Medical Inc., a Delaware corporation (the “Company”), hereby grants to the Grantee named below, on the Grant Date set forth below, the right and option to purchase a specified number of shares of the Company’s common stock, par value $0.10 per share (the “Stock”) under the Plan, at the exercise price per share set forth below (the “Option Price”) (which Option Price is 100% of the Fair Market Value per share as of the Grant Date), subject to the vesting schedule and terms and conditions set forth below (the “Award”). Additional terms and conditions of the Option is set forth on this cover sheet, in the attached Nonqualified Stock Option Grant Agreement (together, the “Agreement”), and in the Company’s 2024 CHRO Inducement Plan (as amended from time to time, the “Plan”) and in the Change in Control and Severance Agreement between the Company and the Grantee (or if the Grantee is not party such an agreement, the Company’s standard form of such agreement) (the “CIC and Severance
